甘肃快3怎么样倍投

骨科劉國輝教授團隊在國際權威期刊《Small》發表最新研究成果
發布時間:2019-12-27
訪問次數:248
分享到:

    TANGNIAOBINGCHUANGMIANDEZHILIAOYIZHISHILINCHUANGYISHENGMIANLINDEYIGEZHONGDANANTI。SUIZHUSHENGWUXUEJISHUHEYIYONGCAILIAODEBUDUANFAZHAN,TANGNIAOBINGCHUANGMIANDEZHILIAOQUDELEYIDINGDEJINZHAN。RANERXIANYOUDEZHILIAOSHOUDUANRENGBULIXIANG,DUITANGNIAOBINGCHUANGMIANNANYIYUHEDEJUTIJIZHIZHIJINSHANGWEIWANQUANCHANMING。JINRI,HUAZHONGKEJIDAXUETONGJIYIXUEYUANFUSHUXIEHEYIYUANGUKELIUGUOHUIJIAOSHOUTUANDUI,ZAICHANMINGTANGNIAOBINGHUANZHEXUEYEWAIMITIDUICHUANGMIANYUHEDEYINGXIANGJIQIANZAIDEJIZHIYANJIUFANGMIANQUDEZHONGYAOJINZHAN,WEITANGNIAOBINGCHUANGMIANDEZHILIAOTIGONGLEXINDEYANJIUSILU,YEWEIYOUTANGNIAOBINGYINQIDEQITAXUEGUANXINGBINGBIANZHIMINGLEXINDEYANJIUFANGXIANG。GAICHENGGUOYI“Circulating Exosomal miR-20b-5p Inhibition Restores Wnt9b signaling and Reverses Diabetes-associated Impaired Wound Healing”WEITIYU12YUE23RIZHENGSHIFABIAOZAIGUOJIYILIUQIKAN《Small》(LUNWENLIANJIE:http://onlinelibrary.wiley.com/doi/full/10.1002/smll.201904044)。《Small》SHIDEGUOWileyCHUBANSHEQIXIADINGJIQIKAN,SHUYUZHONGKEYUANGONGCHENGYIQU,YINGXIANGYINZIWEI10.856。

    WAIMITISHIZHIJINGWEI30-150nmDEXIBAOWAINANGPAO,MUQIANYIBEIZHENGSHIQINANGPAONEIHANYOUmicroRNA、lncRNA、circRNADENGJUYOUGUANGFANDIAOKONGZUOYONGDEWUZHI。XUEYEZHONGHANYOUZHONGDUODEWAIMITI,ERZHEXIEWAIMITINENGGOUBEIXUEGUANNEIPIXIBAOTUNSHI,CONGERDIAOKONGTANGNIAOBINGCHUANGMIANDEYUHE。LIUGUOHUIJIAOSHOUTUANDUITONGGUODUITANGNIAOBINGHUANZHEXUEYEZHONGDEWAIMITIJINXINGSHENRUYANJIU,FAXIANTANGNIAOBINGHUANZHEXUEXUNHUANZHONGDEWAIMITIKEBEIRENXUEGUANNEIPIXIBAOTUNSHI。BEINEIPIXIBAOTUNSHIHOUDEWAIMITIZEJIANGQINANGPAOZHONGGAOSHUIPINGDEmicroRNA-20b-5pSHIFANG,CONGERYIZHINEIPIXIBAODEZENGZHI、QIANYIHECHENGXUEGUANNENGLI。YANJIUJIEGUOJINYIBUFAXIANmicroRNA-20b-5pSHITONGGUOZUOYONGYUJINGDIANDEWnt/β-CateninXINHAOTONGLULAIFAHUISHENGWUXUEZUOYONG。GAIXIANGYANJIUCHENGGUOCHANMINGLETANGNIAOBINGHUANZHEXUEXUNHUANDEWAIMITIZHONGGAOSHUIPINGDEmiRNA-20b-5pSHIDAOZHITANGNIAOBINGHUANZHECHUANGMIANYANCHIYUHEDEZHONGYAOFENZI,WEILINCHUANGSHANGZHILIAOTANGNIAOBINGCHUANGMIANTIGONGLEXINDEZHILIAOBADIAN。

    劉國輝教授、米博斌醫師為文章的共同通訊作者。劉國輝教授以課題負責人主持國家自然科學基金4項,以課題負責人、項目骨干身份主持國家重點研發計劃項目2項,以第一負責人主持國家衛計委重點研發計劃2項、省部級科技基金項目12項。課題組成員熊元博士、陳朗碩士和閆晨晨碩士為文章共同第一作者,華中科技大學同濟醫學院附屬協和醫院骨科為該論文唯一第一作者、唯一通訊作者單位。劉國輝教授團隊在國內外發表專業論文260余篇,其中SCI 60余篇,期待將會有更多相關成果產出,為糖尿病創面的治療提供新思想、新技術。(科研處、骨科醫院)

參考文獻
Xiong, Y., Chen, L., Yan, C., Zhou, W., Endo, Y., Liu, J., Hu, L., Hu, Y., Mi, B., Liu, G., Circulating Exosomal miR‐20b‐5p Inhibition Restores Wnt9b Signaling and Reverses Diabetes‐Associated Impaired Wound Healing. Small 2019, 1904044. http://doi.org/10.1002/smll.201904044.

相關閱讀:
友情鏈接
微信服務號二維碼
微信訂閱號二維碼
Copyrights ? 2002-2015 All Rights Reserved. 醫院地址:湖北省武漢市解放大道1277號 郵編:430022 鄂ICP備 05004666  
醫院總機:027-85726114